Document is current
Any future updates will be listed below
-
Authors
Shaikho, Elmutaz M.
Farrell, John J.
Alsultan, Abdulrahman
Qutub, Hatem
Al-Ali, Amein K.
Figueiredo, Maria Stella
Chui, David H.K.
Farrer, Lindsay A.
Murphy, George J.
Mostoslavsky, Gustavo
Sebastiani, Paola
Steinberg, Martin H.
-
Funding
Funding for this research was provided by:
National Institutes of Health (T32 HL007501, R01 HL 068970, RC2 HL 101212, R01 87681)
- License Information
-
More Information
Article History
Received: 12 June 2017
Accepted: 3 August 2017
First Online: 11 August 2017
Ethics approval and consent to participate
: These studies used non-identifiable archived data from cohort studies of sickle cell anemia patients from the United States and Saudi Arabia, as reported previously (paper references Alsultan et al., 2011, Solovieff et al., 2010). Because of the DNA samples for the CSSCD were obtained from NIH Biolinc, no consents were available. For the Saudi patients, approval was obtained from the IRB at King Saud University, Riyadh, (09-668).
: The authors declare no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
